Atlas Trials

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Clinical trial NCT05239663 · TERMINATED

Trial details

NCT number
NCT05239663
Sponsor
Sun Yat-sen University
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Chemotherapy-Related Cognitive ImpairmentBreast Cancer
Start date
2022-02-08
Primary completion
2024-07-31
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.